Details of the Drug

General Information of Drug (ID: DML46SK)

Drug Name

CGF166

Indication

Disease Entry	ICD 11	Status	REF
Deafness	AB52	Phase 1/2	[1]
------------------------------------------------------------------------------------

Drug Type

Gene therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02132130) Safety, Tolerability and Efficacy for CGF166 in Patients With Unilateral or Bilateral Severe-to-profound Hearing Loss. U.S. National Institutes of Health.